Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride

JACC Cardiovasc Imaging. 2011 Oct;4(10):1119-22. doi: 10.1016/j.jcmg.2011.09.001.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use*
  • Aorta / drug effects*
  • Aortic Diseases / drug therapy*
  • Aortography*
  • Atherosclerosis / diagnosis*
  • Atherosclerosis / drug therapy*
  • Carotid Artery Diseases / drug therapy*
  • Contrast Media*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / drug therapy*
  • Female
  • Fluorodeoxyglucose F18*
  • Glucose Intolerance / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Inflammation / diagnosis*
  • Inflammation / drug therapy*
  • Magnetic Resonance Angiography*
  • Male
  • Multimodal Imaging*
  • Pioglitazone
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Sulfonylurea Compounds / therapeutic use*
  • Thiazolidinediones / pharmacology*
  • Thiazolidinediones / therapeutic use*
  • Tomography, X-Ray Computed*

Substances

  • Anti-Inflammatory Agents
  • Contrast Media
  • Hypoglycemic Agents
  • Radiopharmaceuticals
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Fluorodeoxyglucose F18
  • glimepiride
  • Pioglitazone